Shopping Cart
- Remove All
- Your shopping cart is currently empty
L-902688 is an orally active EP4 receptor agonist (Ki: 0.38 nM; EC50: 0.6 nM). L-902688 displays >4,000-fold selective for EP4 over other EP and prostanoid receptors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
500 μg | $280 | 35 days | |
1 mg | $530 | 35 days | |
5 mg | $2,360 | 35 days | |
10 mg | $4,170 | 35 days |
Description | L-902688 is an orally active EP4 receptor agonist (Ki: 0.38 nM; EC50: 0.6 nM). L-902688 displays >4,000-fold selective for EP4 over other EP and prostanoid receptors. |
Targets&IC50 | EP4:0.38 nM (ki), EP4:0.6 nM (EC50) |
In vitro | L-902688 (1 μM; 24 hours; HUVE cells) treatment, decreases TGF-β-induced Twist and α-smooth muscle actin (α-SMA) expression. |
In vivo | In the monocrotaline (MCT)-induced PAH rat model, L-902688 (0.25-1 μg/kg/day; intraperitoneal injection; daily; for 3 weeks; adult male Sprague-Dawley rats) treatment decreases right ventricle fibrosis [1]. |
Molecular Weight | 419.47 |
Formula | C21H27F2N5O2 |
Cas No. | 634193-54-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.